Aastrom Biosciences insider just cashed-in 30,000 options

Paul K Wotton, an insider of Aastrom Biosciences, recently cashed-in 30,000 options. The options were exercised at prices ranging between $2.76 and $3.74, while the disposals took place at $12.06 per share, on June 18, 2018. Wotton no longer owns any shares of the company. Wotton operates out of Cambridge, MA. Some additional info was provided as follows:

The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 18, 2018. The options, representing a right to purchase a total of 5,000 shares, became exercisable in twelve equal monthly installments beginning on March 20, 2015, which was the date on which the option was granted. The options, representing a right to purchase a total of 10,000 shares, became exercisable in twelve equal monthly installments beginning on May 4, 2016, which was the date on which the option was granted. The options, representing a right to purchase a total of 15,000 shares, became exercisable in thirty six equal monthly installments beginning on March 20, 2015, which was the date on which the option was granted.

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever Aastrom Biosciences makes a similar move, sign up!

Other recent filings from the company include the following:

Aastrom: Vericel Announces Submission Of Biologics License Application To The Fda For Nexobrid For The Treatment Of Severe Thermal Burns - June 30, 2020
Aastrom Biosciences insider just cashed-in 14,751 options - June 24, 2020
Aastrom Biosciences insider just disposed of 1,112 shares - June 18, 2020
Brown Capital Management, LLC just provided an update on share ownership of Aastrom Biosciences - June 10, 2020

Auto Refresh

Feedback